Corcoran Andrea
SEC CIK 1296996 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | See Remarks | 823.6K | — | $60.8K | 8 | 2024-01-31 | 2026-03-11 |
Most active insiders at AVIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Murphy Polly A. | Dir | $25.4K | — |
| 2 | Adams Jerome M. | Dir | — | — |
| 3 | Hammond Janet MJ | Chief Development Off | — | — |
| 4 | Vavricka John | Chief Commercial Off | — | — |
| 5 | Lucidi Bruno | Dir | — | — |
| 6 | Horga Maria Arantxa | Chief Medical Off | — | — |
| 7 | Foster Wayne | EVP, CAO | — | — |
| 8 | Polsky Bruce | Dir | — | — |
| 9 | DUNCAN BARBARA GAYLE | Dir | — | — |
| 10 | Corcoran Andrea | See Remarks | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-13 | 2026-03-11 | AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | M - OptEx | $1.24 | +60.0K | 823.6K | +8% | +$74.4K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | M - OptEx | — | +54.9K | 779.7K | +8% | — |
| D | 2026-02-03 | 2026-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | F - Tax | $4.24 | -16.1K | 763.6K | -2% | -$68.3K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | F - Tax | $3.06 | -16.1K | 717.3K | -2% | -$49.3K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | A - Grant | — | +10.5K | 733.4K | +1% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | M - OptEx | — | +44.4K | 722.9K | +7% | — |
| D | 2024-02-02 | 2024-02-01 | AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | S - Sale+OE | $3.84 | -15.8K | 670.2K | -2% | -$60.8K |
| D | 2024-02-02 | 2024-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | M - OptEx | — | +44.4K | 686.1K | +7% | — |
Purchase Sale Sale after option exercise All abbreviations